Quarter Comparison
Revenue
Operating Income
Gross Margin
Net Margin
Income Statement
Cash Flow Statement
Balance Sheet
Earnings Release
EX-99.1 2 ef20080204_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE August 13, 2026 Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin Recent capital raise and warrant exercises extend cash runwa
EX-99.1 2 ef20080204_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE August 13, 2026 Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin Recent capital raise and warrant exercises extend cash runway through second quarter of 2027 Conference call begins at 9:00 a.m. Eastern time today MINNEAPOLIS – August 13, 2026 – Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today reported financial results for the three and six months ended June 30, 2026. Second Quarter Results and Recent Highlights: ● Net sales were $2.0 million in the second quarter, a 14% increase compared with the prior-year period; U.S. revenue increased 17% ● Net sales for the first six months of 2026 were $4.4 million, a 20% increase comp...
Source
Exhibit EX-99.1
0001140361-26-032838
Filed August 13, 2026 at 8:38 PM UTC. The figures above are from the audited statements, not from this release.